1989
DOI: 10.1164/ajrccm/140.1.255
|View full text |Cite
|
Sign up to set email alerts
|

Guidelines For Percutaneous Transthoracic Needle Biopsy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
11
0

Year Published

1992
1992
2020
2020

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 36 publications
(11 citation statements)
references
References 1 publication
0
11
0
Order By: Relevance
“…The use of automated biopsy devices for transthoracic lung biopsy would result in routine histologic specimens, which might increase the accuracy of the diagnosis of benign disease, thymoma, and lymphoma, which are difficult to diagnose from cytologic samples [9,10]. Furthermore, the need for an experienced cytopathologist in the radiology suite might be diminished, a requirement that was highly recommended by the American Thoracic Society [17], and its value was proved in a recent study [18]. This point would be specially advantageous in Europe because experienced cytopathologists are rare, and in most settings it is impossible for a cytopathologist to attend the biopsy procedure.…”
Section: Discussionmentioning
confidence: 99%
“…The use of automated biopsy devices for transthoracic lung biopsy would result in routine histologic specimens, which might increase the accuracy of the diagnosis of benign disease, thymoma, and lymphoma, which are difficult to diagnose from cytologic samples [9,10]. Furthermore, the need for an experienced cytopathologist in the radiology suite might be diminished, a requirement that was highly recommended by the American Thoracic Society [17], and its value was proved in a recent study [18]. This point would be specially advantageous in Europe because experienced cytopathologists are rare, and in most settings it is impossible for a cytopathologist to attend the biopsy procedure.…”
Section: Discussionmentioning
confidence: 99%
“…determine its use in individual cases". 6 In narrative overviews of the use of TNAB in localised pulmonary lesions, sensitivity of TNAB for the diagnosis of malignancy was reported to range from 64% to 100%. 7 8 Similarly, sensitivity of TNAB for the specific benign diagnosis was reported to range from 11.7% to 68%.…”
mentioning
confidence: 99%
“…The indications for the biopsy technique complied with ATS guidelines (12). Contraindications were: no consent from patient or his/her representative; severe coagulation disorders (platelets < 60 x 10 9 /l or prothrombin activity < 60%); suspected vascular lesion; suspected hydatidosis; patients needing assisted ventilation; severe pulmonary hypertension; chronic obstructive pulmonary disease with bullae documented by radiography; and lesions less than I em in diameter.…”
Section: Methodsmentioning
confidence: 99%